Decreased Fibrinolysis

Name
Decreased Fibrinolysis
Accession Number
DBCAT004136
Description

Not Available

Drugs
DrugDrug Description
Aminocaproic acidAn antifibrinolytic agent used to induce clotting postoperatively.
Tranexamic acidAn antifibrinolytic used to reduce or prevent hemorrhagic episodes, especially in the context of hyperfibrinolytic disorders.
AprotininA serine protease inhibitor used to reduce the risk for perioperative blood loss and the need for blood transfusion in high-risk patients during cardiopulmonary bypass for coronary artery bypass graft surgery.
Drugs & Drug Targets
DrugTargetType
Aminocaproic acidPlasminogentarget
Aminocaproic acidTissue-type plasminogen activatortarget
Aminocaproic acidApolipoprotein(a)target
Aminocaproic acidAldehyde oxidaseenzyme
Tranexamic acidPlasminogentarget
AprotininTrypsin-1target
AprotininChymotrypsinogen Btarget
AprotininPlasminogentarget
AprotininKallikrein-1target
AprotininCholinesteraseenzyme